Westminster, CA , Oct. 16, 2017 -- -- BioLargo, Inc. (OTCQB:BLGO), a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver clean water, clean air and advanced wound care, announced today that it had received a High Tech Innovation award as the “Best Horizontal Disruption” company at OCTANe’s (www.octaneoc.org) 24th annual award ceremony, held at the Balboa Bay Resort on October 12, 2017. OCTANe is Orange County's leading technology and life sciences small business accelerator organization. This awards program (www.octanehta.com) honors Orange County-based companies who have demonstrated exceptional leadership in developing new technological advancements in their respective industries.
Awards were given to recognize outstanding innovators in categories including software, digital strategy, device and hardware, healthcare, medical technology, digital communications, intelligent data analytics, horizontal disruption, intrapreneurship and corporate culture. Nearly 100 prestigious companies in the Orange County area were nominated for an award this year and from that group, 30 were named as finalists. The winners were then selected by a panel of 12 independent judges.
The 2017 finalists were:
|
|
The OCTANe High Tech Innovation Awards were sponsored by BNY Mellon, Deloitte, Grant Thornton, Haskell & White, RSM, Savills Studley, Stradling, Squar Milner, TriNet, UPS and Woodruff Sawyer.
President & CEO of BioLargo, Dennis P. Calvert commented, “This very important milestone recognizing our team, our technology and our continuing mission to make life better. We are proud to receive this prestigious recognition from OCTANe.”
About BioLargo, Inc.
BioLargo, Inc. is a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver clean water, clean air and advanced wound care. More information can be found about the company at www.BioLargo.com. Its engineering division (www.BioLargoEngineering.com) features an exceptional team of experienced specialists dedicated to integrity, reliability, safety, and environmental stewardship. It water division (www.BioLargoWater.com) showcases its emerging technology, the Advanced Oxidation System “AOS”, an award-winning product, having been awarded more than 35 research grants and counting, specifically designed to eliminate common, troublesome, and dangerous contaminants in water in a fraction of the time and cost of current technologies. Its odor division features sustainable odor elimination products including its CupriDyne Clean (www.CupriDyne.com) Industrial Odor Eliminator, a product currently serving the leading solid waste handling and wastewater treatment companies as well as any industry that that contends with malodors, VOC’s or similar air quality related problems. Its personal care product division features products in the pet, equine, military supply and consumer markets, and include the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). Its medical division (www.ClyraMedical.com) focuses on advanced wound care management, featuring effective and gentle solutions for chronic infected wounds and other uses to promote infection control and regenerative tissue therapy. BioLargo also owns a 50% interest in the Isan System, a fully automated iodine dosing system being commercialized under a license to Clarion Water, Inc (www.ClarionWater.com).
About OCTANe
OCTANe drives innovation and growth by connecting people, resources and capital to fuel technology growth in Southern California. Its members represent technology executive leaders, entrepreneurs, investors, venture capitalists, academicians, and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 800 companies via the LaunchPad™ SBDC accelerator. LaunchPad™ companies have received more than $2.1 billion in investment and equity exits. OCTANe annually welcomes more than 7,000 people to its programs and events. More than 2,000 business leaders throughout the region are OCTANe members. For more information, visit www.octaneoc.org.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
Company Contact Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



